Portage Biotech Inc expected to post a loss of 24 cents a share - Earnings Preview

Alpha Compute

25/08/2023 13:02

* Portage Biotech Inc  PRTG.OQ   PRTG.O  is expected to show
no
change in quarterly revenue when it reports  results on August
28 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Portage Biotech Inc
is
for a loss of 24 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 1,772.4% in the last three months. ​
    * Wall Street's median 12-month price target for Portage
Biotech
Inc is $10​, above​ its last closing price of $2.78. ​​​

This summary was machine generated August 25 at 12:02 GMT.  All
figures in US dollars  unless otherwise stated